UA93489C2 - Гетероциклические соединения kak антагонисты ccr2b - Google Patents

Гетероциклические соединения kak антагонисты ccr2b

Info

Publication number
UA93489C2
UA93489C2 UAA200706266A UAA200706266A UA93489C2 UA 93489 C2 UA93489 C2 UA 93489C2 UA A200706266 A UAA200706266 A UA A200706266A UA A200706266 A UAA200706266 A UA A200706266A UA 93489 C2 UA93489 C2 UA 93489C2
Authority
UA
Ukraine
Prior art keywords
heterocyclic compounds
formula
yand
alkyl
ccr2b
Prior art date
Application number
UAA200706266A
Other languages
English (en)
Ukrainian (uk)
Inventor
Джастин Ферфилд Бауэр
Джеффри Филип Пойзер
Пол Тернер
Дейвид Вотерсон
Джон Винтер
Original Assignee
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб filed Critical Астразенека Аб
Publication of UA93489C2 publication Critical patent/UA93489C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Соединения формулы (I)(I)и их фармацевтически приемлемые соли или сольваты, которые являются полезными в лечении опосредованных хемокином С-С состояний.
UAA200706266A 2004-12-24 2005-12-19 Гетероциклические соединения kak антагонисты ccr2b UA93489C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0428327A GB0428327D0 (en) 2004-12-24 2004-12-24 Method

Publications (1)

Publication Number Publication Date
UA93489C2 true UA93489C2 (ru) 2011-02-25

Family

ID=34130900

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200706266A UA93489C2 (ru) 2004-12-24 2005-12-19 Гетероциклические соединения kak антагонисты ccr2b

Country Status (4)

Country Link
CN (1) CN101128427B (ru)
GB (1) GB0428327D0 (ru)
UA (1) UA93489C2 (ru)
ZA (1) ZA200705159B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100152197A1 (en) * 2008-12-15 2010-06-17 Astrazeneca Ab (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
MX2022002720A (es) * 2019-09-05 2022-08-10 Lunan Pharmaceutical Group Corp Inhibidor de magl, procedimiento de preparacion y uso del mismo.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07502014A (ja) * 1991-06-21 1995-03-02 ベーリンガー　マンハイム　イタリア　エス．ピー．エイ． 気道に対して抗喘息性、抗炎症性活性を有する２−アミノ−４−アリール−チアゾール
EP1334089A1 (en) * 2000-11-13 2003-08-13 GlaxoSmithKline S.p.A. Quinoline derivatives as nk-3 and nk-2 antagonists
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
WO2002079151A1 (en) * 2001-03-29 2002-10-10 Smithkline Beecham P.L.C. 3-substituted indoels or fused pyrroles as antagonists of the chemokine mcp-1 (ccr2b) receptor
CA2502178A1 (en) * 2002-10-30 2004-05-21 Merck & Co., Inc. Heteroarylpiperidine modulators of chemokine receptor activity
FR2872813B1 (fr) * 2004-07-09 2007-01-19 Sanofi Synthelabo Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CN101128427B (zh) 2013-03-27
ZA200705159B (en) 2008-06-25
CN101128427A (zh) 2008-02-20
GB0428327D0 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
MX2007007428A (es) Compuestos heterociclicos, antagonistas de ccr2b.
BRPI0413233A (pt) novos compostos
PE20130012A1 (es) Derivados de pirazol como inhibidores de jak
AR058403A1 (es) PIRIMIDINILOXI Y PIRIDINILOXI UREAS SUSTITUíDAS COMO INHIBIDORES DE PROTEíNA QUINASAS, COMPOSICIONES FARMACÉUTICAS QUE LAS CONTIENEN Y SU USO EN LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR LA ACTIVIDAD BASAL DE B-RAF.
PE20120224A1 (es) Derivados de 1h-imidazo-[4,5-c]-quinolinona
HRP20050933A2 (en) Organic compounds
PE20141827A1 (es) Inhibidores de proteinas quinasas
MX2010004819A (es) Derivados de [1h-pirazolo[3,4-b]piridin-4-il]-fenilo o piridin-2-ilo como proteina cinasa c-theta.
TW200606151A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
BRPI0406762A (pt) Derivados de n-(1-benzil-2-oxo-2-(1-piperazinil)etil)-1-piperidincarb oxamida e compostos relacionados como antagonistas de cgrp, para tratamento de dores de cabeça
EA201101566A1 (ru) Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ
TW200603799A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
MX2010000658A (es) Derivados de pirimidina 934.
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
ECSP066474A (es) Arilindenopiridinas y arilindenopirimidinas y su uso como antagonista del receptor adenosina a2a
MX2009006018A (es) Derivados de quinuclidinol como antagonistas de receptores muscarinicos.
TW200616636A (en) Novel compounds
PE20070212A1 (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
ATE473973T1 (de) Substituierte benzimidazole und deren verwendung zur induktion von apoptose
ATE409179T1 (de) Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten
ATE541839T1 (de) Pyrrolidiniumderivate als m3-muskarinische rezeptoren
MX2011011764A (es) Compuestos de carboxamida y su uso como inhibidores de calpaina.
PE20081492A1 (es) Derivados de sulfonamida heterociclicos como antagonista de edg-1
PE20061078A1 (es) Derivados de piridotienopirimidina como inhibidores de la fosfodiesterasa 4 (pde4)
MX2009008323A (es) Derivados heterociclicos como receptores muscarinicos m3.